U.S. Chamber: Administration’s Price Controls on Drugs Will Leave America Unprepared for Next Pandemic

WASHINGTON, D.C. – U.S. Chamber of Commerce Executive Vice President and Chief Policy Officer Neil Bradley released the following statement today after the White House announcement on drug pricing:

“America’s pharmaceutical companies created safe, effective COVID vaccines in record time because of years of investments in research. The price controls proposed by the Biden administration are nothing more than a tax on the research investments that have made break-throughs, like the COVID vaccines, possible. Price controls will result in less research investment and fewer U.S. jobs, leaving America unprepared for the next public health crisis and delaying the development of treatments for cancer, Alzheimer’s and many other diseases. We will work to make sure these policies are not implemented.”


Global Innovation Policy Center (GIPC) @globalIPcenter 1h

“As consumers increasingly purchase from online or third-party vendors, our officers are at the frontline to guard against defrauders expecting to make money selling fake merchandise.” More from @CBP: https://t.co/SxIvwS5pF7

Reply Retweet Favorite

Subscribe for updates from GIPC